Response to Office Action

TERIL

Taro Pharmaceutical Industries Ltd.

Response to Office Action

PTO Form 1957 (Rev 9/2005)
OMB No. 0651-0050 (Exp. 04/30/2011)

Response to Office Action


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 85086648
LAW OFFICE ASSIGNED LAW OFFICE 116
MARK SECTION (no change)
GOODS AND/OR SERVICES SECTION (current)
INTERNATIONAL CLASS 005
DESCRIPTION
Pharmaceutical preparations for the treatment of epilepsy and neuralgy, pharmaceutical preparations, namely, carbamazepine
GOODS AND/OR SERVICES SECTION (proposed)
INTERNATIONAL CLASS 005
DESCRIPTION
Pharmaceutical preparations for the treatment of epilepsy and neuralgy, pharmaceutical preparations, namely, carbamazepine
FILING BASIS Section 1(b)
SIGNATURE SECTION
       ORIGINAL PDF FILE HS_2161418183-121720365_._ITU_Declaration_-_for_TERIL.pdf
       CONVERTED PDF FILE(S)
       (2 pages)
\\TICRS\EXPORT11\IMAGEOUT11\850\866\85086648\xml5\ROA0002.JPG
        \\TICRS\EXPORT11\IMAGEOUT11\850\866\85086648\xml5\ROA0003.JPG
SIGNATORY'S NAME Stephen Manzano
SIGNATORY'S POSITION Vice President, Associate General Counsel
RESPONSE SIGNATURE /Marcia A. Auberger/
SIGNATORY'S NAME Marcia A. Auberger
SIGNATORY'S POSITION Attorney of Record
DATE SIGNED 03/15/2011
AUTHORIZED SIGNATORY YES
FILING INFORMATION SECTION
SUBMIT DATE Tue Mar 15 12:55:39 EDT 2011
TEAS STAMP USPTO/ROA-XXX.XXX.XX.XX-2
0110315125539873411-85086
648-48045c9956a2590c79d81
3321119b191cec-N/A-N/A-20
110315121720365321



PTO Form 1957 (Rev 9/2005)
OMB No. 0651-0050 (Exp. 04/30/2011)

Response to Office Action


To the Commissioner for Trademarks:

Application serial no. 85086648 has been amended as follows:

CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 005 for Pharmaceutical preparations for the treatment of epilepsy and neuralgy, pharmaceutical preparations, namely, carbamazepine
Original Filing Basis:
Proposed: Class 005 for Pharmaceutical preparations for the treatment of epilepsy and neuralgy, pharmaceutical preparations, namely, carbamazepine
Filing Basis: Section 1(b), Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services as of the filing date of the application. (15 U.S.C. Section 1051(b)).

SIGNATURE(S)
Declaration Signature
Original PDF file:
HS_2161418183-121720365_._ITU_Declaration_-_for_TERIL.pdf
Converted PDF file(s) (2 pages)
Signature File1
Signature File2
Signatory's Name: Stephen Manzano
Signatory's Position: Vice President, Associate General Counsel

Response Signature
Signature: /Marcia A. Auberger/     Date: 03/15/2011
Signatory's Name: Marcia A. Auberger
Signatory's Position: Attorney of Record

The signatory has confirmed that he/she is an attorney who is a member in good standing of the bar of the highest court of a U.S. state, which includes the District of Columbia, Puerto Rico, and other federal territories and possessions; and he/she is currently the applicant's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S. attorney or a Canadian attorney/agent not currently associated with his/her company/firm previously represented the applicant in this matter: (1) the applicant has filed or is concurrently filing a signed revocation of or substitute power of attorney with the USPTO; (2) the USPTO has granted the request of the prior representative to withdraw; (3) the applicant has filed a power of attorney appointing him/her in this matter; or (4) the applicant's appointed U.S. attorney or Canadian attorney/agent has filed a power of attorney appointing him/her as an associate attorney in this matter.

        
Serial Number: 85086648
Internet Transmission Date: Tue Mar 15 12:55:39 EDT 2011
TEAS Stamp: USPTO/ROA-XXX.XXX.XX.XX-2011031512553987
3411-85086648-48045c9956a2590c79d8133211
19b191cec-N/A-N/A-20110315121720365321


Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed